 | • レポートコード：MRC2307A0044 • 出版社/出版日：Transparency Market Research / 2023年5月 • レポート形態：英文、PDF、182ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当市場調査書によると、世界のセントラルラボ市場規模が、2023年の26億ドルから2031年までに41億ドルに達し、予測期間中にCAGR（年平均成長率）5.1%で拡大すると予想されています。本書は、セントラルラボの世界市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、主要インサイト、製品別（遺伝子サービス、バイオマーカーサービス、微生物学サービス、解剖病理学/組織学、その他）分析、エンドユーザー別（製薬企業、バイオテクノロジー企業、学術・研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。なお、ACM Global Laboratories、Barc Lab (Cerba Research)、Bioscientia (Sonic Healthcare)、Celerion、CIRION BioPharma Research、Clinical Reference Laboratory、Eurofins Central Laboratory、Frontage Laboratories, Inc.、ICON Central Laboratoriesなど、主要企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・主要インサイト ・世界のセントラルラボ市場規模：製品別 - 遺伝子サービスの市場規模 - バイオマーカーサービスの市場規模 - 微生物学サービスの市場規模 - 解剖病理学/組織学の市場規模 - その他製品の市場規模 ・世界のセントラルラボ市場規模：エンドユーザー別 - 製薬企業における市場規模 - バイオテクノロジー企業における市場規模 - 学術・研究機関における市場規模 ・世界のセントラルラボ市場規模：地域別 - 北米のセントラルラボ市場規模 - ヨーロッパのセントラルラボ市場規模 - アジア太平洋のセントラルラボ市場規模 - 中南米のセントラルラボ市場規模 - 中東・アフリカのセントラルラボ市場規模 ・競争状況 |
Central Lab Market – Scope of Report
TMR’s report on the global Central Lab market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Central Lab market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Central Lab market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Central Lab market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Central Lab market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Central Lab market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Central Lab market.
The report delves into the competitive landscape of the global Central Lab market. Key players operating in the global Central Lab market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Central Lab market profiled in this report.
Key Questions Answered in Global Central Lab Market Report
• What is the sales/revenue generated by Central Lab across all regions during the forecast period?
• What are the opportunities in the global Central Lab market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Central Lab Market – Research Objectives and Research Approach
The comprehensive report on the global Central Lab market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Central Lab market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Central Lab market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Central Lab Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Central Lab Market Analysis and Forecast, 2017 – 2031
5. Key Insights
5.1. Strategies Adopted by Top 3 Players
5.2. Impact of Cell and Gene Therapy on Central Lab Market
5.3. Impact of Clinical Trial on Central Lab Market
5.4. COVID-19 Impact Analysis
6. Global Central Lab Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2017 – 2031
6.3.1. Genetic Services
6.3.2. Biomarker Services
6.3.3. Microbiology Services
6.3.4. Anatomic Pathology/Histology
6.3.5. Specimen Management & Storage
6.3.6. Special Chemistry Services
6.3.7. Clinical Research & Trial Services
6.3.8. Others
6.4. Market Attractiveness By Product
7. Global Central Lab Market Analysis and Forecast, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2017 – 2031
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Academic & Research Institutes
7.4. Market Attractiveness By End-user
8. Global Central Lab Market Analysis and Forecast, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Central Lab Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2017 – 2031
9.2.1. Genetic Services
9.2.2. Biomarker Services
9.2.3. Microbiology Services
9.2.4. Anatomic Pathology/Histology
9.2.5. Specimen Management & Storage
9.2.6. Special Chemistry Services
9.2.7. Clinical Research & Trial Services
9.2.8. Others
9.3. Market Value Forecast By End-user, 2017 – 2031
9.3.1. Pharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Academic & Research Institutes
9.4. Market Value Forecast By Country, 2017 – 2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Central Lab Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2017 – 2031
10.2.1. Genetic Services
10.2.2. Biomarker Services
10.2.3. Microbiology Services
10.2.4. Anatomic Pathology/Histology
10.2.5. Specimen Management & Storage
10.2.6. Special Chemistry Services
10.2.7. Clinical Research & Trial Services
10.2.8. Others
10.3. Market Value Forecast By End-user, 2017 – 2031
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Academic & Research Institutes
10.4. Market Value Forecast By Country, 2017 – 2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific Central Lab Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2017 – 2031
11.2.1. Genetic Services
11.2.2. Biomarker Services
11.2.3. Microbiology Services
11.2.4. Anatomic Pathology/Histology
11.2.5. Specimen Management & Storage
11.2.6. Special Chemistry Services
11.2.7. Clinical Research & Trial Services
11.2.8. Others
11.3. Market Value Forecast By End-user, 2017 – 2031
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Academic & Research Institutes
11.4. Market Value Forecast By Country, 2017 – 2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country
12. Latin America Central Lab Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2017 – 2031
12.2.1. Genetic Services
12.2.2. Biomarker Services
12.2.3. Microbiology Services
12.2.4. Anatomic Pathology/Histology
12.2.5. Specimen Management & Storage
12.2.6. Special Chemistry Services
12.2.7. Clinical Research & Trial Services
12.2.8. Others
12.3. Market Value Forecast By End-user, 2017 – 2031
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Academic & Research Institutes
12.4. Market Value Forecast By Country, 2017 – 2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa Central Lab Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2017 – 2031
13.2.1. Genetic Services
13.2.2. Biomarker Services
13.2.3. Microbiology Services
13.2.4. Anatomic Pathology/Histology
13.2.5. Specimen Management & Storage
13.2.6. Special Chemistry Services
13.2.7. Clinical Research & Trial Services
13.2.8. Others
13.3. Market Value Forecast By End-user, 2017 – 2031
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Academic & Research Institutes
13.4. Market Value Forecast By Country, 2017 – 2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2022)
14.3. Company Profiles
14.3.1. ACM Global Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Test Type Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Barc Lab (Cerba Research)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Test Type Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Bioscientia (Sonic Healthcare)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Test Type Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Celerion
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Test Type Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. CIRION BioPharma Research
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Test Type Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Clinical Reference Laboratory
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Test Type Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Eurofins Central Laboratory
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Test Type Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Frontage Laboratories, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Test Type Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. ICON Central Laboratories
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Test Type Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. INTERLAB Central Lab Services
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Test Type Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. InVitro International
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Test Type Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Labcorp/Covance
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Test Type Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. LabConnect
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Test Type Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Medpace
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Test Type Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. MLM Medical Labs GmbH
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Test Type Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
14.3.16. PPD
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Test Type Portfolio
14.3.16.3. Financial Overview
14.3.16.4. SWOT Analysis
14.3.16.5. Strategic Overview
14.3.17. Q² Solutions
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Test Type Portfolio
14.3.17.3. Financial Overview
14.3.17.4. SWOT Analysis
14.3.17.5. Strategic Overview
Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031